Univercells S.A. (Univercells) today announced its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented robust, scalable and automated DNA synthesis technology resulting in one-step generation of long DNA fragments, at large quantities, high purity in a cGMP-compliant setup. SynHelix’s offering will complement the RNA platform being developed by […]

MENLO PARK, Calif. — PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBio’s HiFi sequencing platforms across Azenta’s newly combined company and support Azenta’s mission to enable life science companies to deliver impactful breakthroughs and therapies to market faster. […]

– Twist launches expert-designed panel that facilitates canine genomic research in partnership with Broad Institute Vertebrate Genomics Group – – Canine research could benefit research into several human diseases, including cancer – SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic […]

THIS PARTNERSHIP WILL HELP BIOMEDICAL RESEARCHERS ACCESS AND ANALYZE DATA FROM SINGULAR GENOMICS SYSTEMS AND EASILY COLLABORATE ON THE CLOUD USING A SECURE, SCALABLE AND OPEN SOURCE INFORMATIC PLATFORM LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today […]

NORCROSS, GA. Omega Bio-tek, a leading nucleic acid purification kit manufacturer, announces its new plant genomic DNA purification kit, the E-Z 384 Plant DNA HT Kit. The new 384-well silica filter plate-based kit is capable of isolating genomic DNA from up to 768 samples in 1.5 hours when processing two plates in parallel. This kit […]

SEATTLE — Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of its new platform for precision oncology. The OncoTerra platform implements a rapid, cost-effective alternative to current cytogenomic analysis tools while unlocking information in even the most challenging of sample types. […]

Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina’s current and future high throughput next-generation sequencing (NGS) platforms. This partnership […]

Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership […]

BOULDER, Colo. — Inscripta, Inc., The Digital Genome Engineering Company, today announced that it has appointed Kristala Prather, PhD, to serve on its Board of Directors. Dr. Prather is currently the Arthur D. Little Professor and Executive Officer of the Department of Chemical Engineering at MIT. “We are very excited to have Kris join our board. […]

MENLO PARK, Calif. — PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa, includes 21 academic sites across […]